First Trust Advisors
SYRE icon

First Trust Advisors’s Spyre Therapeutics SYRE Stock Holding History

First Trust Advisors’s Portfolio SYRE Stock Details SYRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-23,550
Closed -$548K – 2619
2024
Q4 		$548K Buy
+23,550
New +$548K ﹤0.01% 2220